These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 8669830

  • 1. Modification of the blood-brain barrier permeability following intracarotid infusion of vinorelbine.
    Mouchard-Delmas C, Gourdier B, Vistelle R, Wiczewski M.
    Anticancer Res; 1995; 15(6B):2593-6. PubMed ID: 8669830
    [Abstract] [Full Text] [Related]

  • 2. Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.
    Spigelman MK, Zappulla RA, Strauchen JA, Feuer EJ, Johnson J, Goldsmith SJ, Malis LI, Holland JF.
    Cancer Res; 1986 Mar; 46(3):1453-7. PubMed ID: 3510725
    [Abstract] [Full Text] [Related]

  • 3. Modification of the blood-brain barrier permeability by vinorelbine: effect of intracarotid infusion compared with intravenous infusion.
    Mouchard-Delmas C, Gourdier B, Vistelle R, Wiczewski M.
    Anticancer Drugs; 1996 Feb; 7(2):213-9. PubMed ID: 8740728
    [Abstract] [Full Text] [Related]

  • 4. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
    Maeda Y, Matsumoto K, Mizumatsu S, Tamiya T, Furuta T, Ohmoto T.
    Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
    [Abstract] [Full Text] [Related]

  • 5. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
    Kaya M, Gulturk S, Elmas I, Kalayci R, Arican N, Kocyildiz ZC, Kucuk M, Yorulmaz H, Sivas A.
    Life Sci; 2004 Nov 26; 76(2):201-12. PubMed ID: 15519365
    [Abstract] [Full Text] [Related]

  • 6. Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate.
    Preston E, Slinn J, Vinokourov I, Stanimirovic D.
    J Neurosci Methods; 2008 Mar 15; 168(2):443-9. PubMed ID: 18155299
    [Abstract] [Full Text] [Related]

  • 7. Evans blue distribution in the rate brain after intracarotid injection with the blood-brain barrier intact and open to osmosis.
    Kozler P, Pokorný J.
    Sb Lek; 2003 Mar 15; 104(3):255-62. PubMed ID: 15224531
    [Abstract] [Full Text] [Related]

  • 8. Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin.
    Brown RC, Egleton RD, Davis TP.
    Brain Res; 2004 Jul 16; 1014(1-2):221-7. PubMed ID: 15213006
    [Abstract] [Full Text] [Related]

  • 9. WR-2721 entry into the brain across a modified blood-brain barrier.
    Lamperti A, Conger AD, Jenkins O, Cohen G, Rizzo A, Davis ME, Sodicoff M.
    Radiat Res; 1988 Aug 16; 115(2):303-13. PubMed ID: 2841714
    [Abstract] [Full Text] [Related]

  • 10. Blood-brain barrier integrity in a rat model of emergency preservation and resuscitation.
    Lahoud-Rahme MS, Stezoski J, Kochanek PM, Melick J, Tisherman SA, Drabek T.
    Resuscitation; 2009 Apr 16; 80(4):484-8. PubMed ID: 19203824
    [Abstract] [Full Text] [Related]

  • 11. Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats.
    Baba T, Black KL, Ikezaki K, Chen KN, Becker DP.
    J Cereb Blood Flow Metab; 1991 Jul 16; 11(4):638-43. PubMed ID: 1675639
    [Abstract] [Full Text] [Related]

  • 12. Effect of indomethacin (a prostaglandin synthetase inhibitor) on the permeability of blood-brain and blood-CSF barriers in rat.
    Dey PK, Sharma HS, Rao KS.
    Indian J Physiol Pharmacol; 1980 Jul 16; 24(1):25-36. PubMed ID: 7364458
    [Abstract] [Full Text] [Related]

  • 13. Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats.
    Pan GY, Liu XD, Liu GQ.
    Acta Pharmacol Sin; 2000 Jul 16; 21(7):613-6. PubMed ID: 11360668
    [Abstract] [Full Text] [Related]

  • 14. Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain.
    Erdlenbruch B, Schinkhof C, Kugler W, Heinemann DE, Herms J, Eibl H, Lakomek M.
    Br J Pharmacol; 2003 Jun 16; 139(4):685-94. PubMed ID: 12812991
    [Abstract] [Full Text] [Related]

  • 15. Quantitative analysis of papaverine-mediated blood-brain barrier disruption in rats.
    Bhattacharjee AK, Kondoh T, Nagashima T, Ikeda M, Ehara K, Tamaki N.
    Biochem Biophys Res Commun; 2001 Nov 30; 289(2):548-52. PubMed ID: 11716508
    [Abstract] [Full Text] [Related]

  • 16. Etoposide-induced blood-brain barrier disruption. Effect of drug compared with that of solvents.
    Spigelman MK, Zappulla RA, Johnson J, Goldsmith SJ, Malis LI, Holland JF.
    J Neurosurg; 1984 Oct 30; 61(4):674-8. PubMed ID: 6470777
    [Abstract] [Full Text] [Related]

  • 17. Blood-brain barrier disruption in the treatment of brain tumors.
    Blanchette M, Fortin D.
    Methods Mol Biol; 2011 Oct 30; 686():447-63. PubMed ID: 21082387
    [Abstract] [Full Text] [Related]

  • 18. Impairment of blood-brain barrier (BBB) in rat by immobilization stress: role of serotonin (5-HT).
    Sharma HS, Dey PK.
    Indian J Physiol Pharmacol; 1981 Oct 30; 25(2):111-22. PubMed ID: 7287133
    [Abstract] [Full Text] [Related]

  • 19. Localized changes in blood-brain barrier permeability following the administration of antineoplastic drugs.
    MacDonell LA, Potter PE, Leslie RA.
    Cancer Res; 1978 Sep 30; 38(9):2930-4. PubMed ID: 679202
    [Abstract] [Full Text] [Related]

  • 20. Effect of intracarotid etoposide on opening the blood-brain barrier.
    Spigelman MK, Zappulla RA, Goldberg JD, Goldsmith SJ, Marotta D, Malis LI, Holland JF.
    Cancer Drug Deliv; 1984 Sep 30; 1(3):207-11. PubMed ID: 6399858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.